,Set,NGenes,Direction,PValue,FDR
1,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.000101752715456471,0.0839459902515883
2,WP_HYPERTROPHY_MODEL,13,Down,0.000332492179507769,0.10800012863679
3,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.00039272774049742,0.10800012863679
4,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.00148243488420441,0.305752194867159
5,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.00232414789913103,0.346264718203884
6,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.00251828885966461,0.346264718203884
7,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.00362126612510922,0.375814069213624
8,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Down,0.00390038084439692,0.375814069213624
9,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.0040997898459668,0.375814069213624
10,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.00472684276981462,0.382857269333515
11,WP_TYPE_II_INTERFERON_SIGNALING,31,Up,0.00535365547711416,0.382857269333515
12,WP_NETRINUNC5B_SIGNALING,35,Down,0.00556883300848749,0.382857269333515
13,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.00613776281649552,0.38591578960211
14,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.00654887400536915,0.38591578960211
15,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00735226245607624,0.404374435084193
16,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0086171452253696,0.406609711872719
17,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.00877582456427908,0.406609711872719
18,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.010211018251485,0.406609711872719
19,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0105412628407924,0.406609711872719
20,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.0110502769503184,0.406609711872719
21,WP_TRANSLATION_FACTORS,49,Down,0.0122654707313946,0.406609711872719
22,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.0125342427283726,0.406609711872719
23,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0135959999833162,0.406609711872719
24,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.01370854810497,0.406609711872719
25,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0137987274474189,0.406609711872719
26,WP_GPCRS_OTHER,13,Down,0.0138503996017915,0.406609711872719
27,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0149214233397522,0.406609711872719
28,WP_GPR40_PATHWAY,7,Down,0.0149475809630251,0.406609711872719
29,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.0149827708008175,0.406609711872719
30,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.0150823689656208,0.406609711872719
31,WP_ALLOGRAFT_REJECTION,50,Down,0.0152786679612779,0.406609711872719
32,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Down,0.0181062169241923,0.461077495503856
33,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.0184430998201542,0.461077495503856
34,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.0190932966554023,0.462037204779751
35,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.0204132632063205,0.462037204779751
36,WP_OREXIN_RECEPTOR_PATHWAY,112,Down,0.0210507304089356,0.462037204779751
37,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.021149792211409,0.462037204779751
38,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.0238231462389875,0.462037204779751
39,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0249966206770838,0.462037204779751
40,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.0251077550300664,0.462037204779751
41,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0255289978075373,0.462037204779751
42,WP_MAPK_SIGNALING,157,Down,0.0260152135862863,0.462037204779751
43,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.026052308368133,0.462037204779751
44,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0269491309054797,0.462037204779751
45,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0273210845298611,0.462037204779751
46,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.0273893924141149,0.462037204779751
47,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.027568756040623,0.462037204779751
48,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0284574102276804,0.462037204779751
49,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Down,0.0293567599370473,0.462037204779751
50,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.029364132471807,0.462037204779751
51,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.0294835389578203,0.462037204779751
52,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.0295766744341367,0.462037204779751
53,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.0296823901252446,0.462037204779751
54,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.0313430053323882,0.470145079985822
55,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.0313430053323882,0.470145079985822
56,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0325172207449953,0.472203846091034
57,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0333003248636337,0.472203846091034
58,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.0336837160216652,0.472203846091034
59,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0337697295992376,0.472203846091034
60,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.0346591163039431,0.476562849179218
61,WP_CREATINE_PATHWAY,2,Down,0.038959688835275,0.526913824411507
62,WP_IL1_SIGNALING,51,Down,0.0441264907942619,0.587167014601066
63,WP_ERBB_SIGNALING,68,Down,0.0455128364052416,0.591542652519685
64,WP_SPINAL_CORD_INJURY,64,Down,0.0458893694075877,0.591542652519685
65,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.049349521981276,0.623248165294417
66,WP_VITAMIN_B12_DISORDERS,9,Up,0.0498598532235533,0.623248165294417
67,WP_TP53_NETWORK,14,Down,0.0513114100510424,0.630830639402737
68,WP_BURN_WOUND_HEALING,62,Down,0.0525574132891919,0.630830639402737
69,WP_EGFEGFR_SIGNALING,138,Down,0.0539353156471369,0.630830639402737
70,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.0544557712445935,0.630830639402737
71,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0547052785464819,0.630830639402737
72,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0550543103478752,0.630830639402737
73,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.0574299982046633,0.631437664579286
74,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.0587866999668189,0.631437664579286
75,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Up,0.0589307696650617,0.631437664579286
76,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,0.0597736206708153,0.631437664579286
77,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.0598827647205989,0.631437664579286
78,WP_RANKLRANK_SIGNALING,47,Down,0.0599132908007147,0.631437664579286
79,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0608040272585364,0.631437664579286
80,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0617627700053369,0.631437664579286
81,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.0619956979768754,0.631437664579286
82,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.0683436073974471,0.675680658283334
83,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.070263402900543,0.675680658283334
84,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0716361822453549,0.675680658283334
85,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.0733256371637752,0.675680658283334
86,WP_IRINOTECAN_PATHWAY,5,Up,0.0733656959430391,0.675680658283334
87,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0734447142493227,0.675680658283334
88,WP_ENDODERM_DIFFERENTIATION,82,Down,0.0737434422604297,0.675680658283334
89,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0739570254367148,0.675680658283334
90,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.0748899054920927,0.675680658283334
91,WP_PROLACTIN_SIGNALING,70,Down,0.0759082029471754,0.675680658283334
92,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0762484812549542,0.675680658283334
93,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0762701529395491,0.675680658283334
94,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0769866447013738,0.675680658283334
95,WP_GASTRIN_SIGNALING,91,Down,0.0787079226017049,0.677199860013523
96,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.0796022389169789,0.677199860013523
97,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0800258303238696,0.677199860013523
98,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.0814270179024484,0.677199860013523
99,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0818085272203062,0.677199860013523
100,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.0832394392446706,0.677199860013523
101,WP_MONOAMINE_TRANSPORT,11,Down,0.0837944230184031,0.677199860013523
102,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0840533394213368,0.677199860013523
103,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.0845473764622944,0.677199860013523
104,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Down,0.0873621230091448,0.680592305711185
105,WP_MAPK_CASCADE,30,Down,0.0873887417963482,0.680592305711185
106,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.0888721615047654,0.680592305711185
107,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.089933375858123,0.680592305711185
108,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Down,0.0902256290994414,0.680592305711185
109,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.0920381598353533,0.680592305711185
110,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.0921685359643372,0.680592305711185
111,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.0925123573870805,0.680592305711185
112,WP_HIPPO_SIGNALING_REGULATION,41,Down,0.0946265313496217,0.680592305711185
113,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.0947711555152988,0.680592305711185
114,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0950242141597876,0.680592305711185
115,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.0956204838827746,0.680592305711185
116,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.0956954029848454,0.680592305711185
117,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.0993143578551677,0.695304336790892
118,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.101495501480562,0.695304336790892
119,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.101967212582595,0.695304336790892
120,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.102801619561332,0.695304336790892
121,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.103433858246465,0.695304336790892
122,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.103686386667773,0.695304336790892
123,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.104219205067651,0.695304336790892
124,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.106026048401073,0.695304336790892
125,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.106245997941412,0.695304336790892
126,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.106416088575583,0.695304336790892
127,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.107833668328915,0.695304336790892
128,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.107877521344526,0.695304336790892
129,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.108984624146212,0.696128156333283
130,WP_NRF2ARE_REGULATION,21,Up,0.109762136278386,0.696128156333283
131,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.111102454652572,0.696128156333283
132,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.111380505013325,0.696128156333283
133,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.113642377863964,0.704924524344136
134,WP_NRXN1_DELETION_SYNDROME,2,Down,0.115580865093905,0.706141488653502
135,WP_PURINE_METABOLISM,10,Down,0.116617391717229,0.706141488653502
136,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.118591009936035,0.706141488653502
137,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.119254974980009,0.706141488653502
138,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.120060703487804,0.706141488653502
139,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.12074973457778,0.706141488653502
140,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.121502924414609,0.706141488653502
141,WP_ATR_SIGNALING,10,Up,0.121849805524456,0.706141488653502
142,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.122761280274825,0.706141488653502
143,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.124060344424949,0.706141488653502
144,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.124695856504002,0.706141488653502
145,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.124706814069812,0.706141488653502
146,WP_KLEEFSTRA_SYNDROME,25,Down,0.124965645264741,0.706141488653502
147,WP_COMPLEMENT_ACTIVATION,11,Down,0.126190648480118,0.708212823102701
148,WP_PLEURAL_MESOTHELIOMA,246,Down,0.129182338409292,0.714803936377526
149,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.129890268712627,0.714803936377526
150,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.130789286868978,0.714803936377526
151,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.130830781082432,0.714803936377526
152,WP_VEGFAVEGFR2_SIGNALING,338,Down,0.138243312786073,0.73299932052882
153,WP_PDGF_PATHWAY,36,Down,0.138802194301261,0.73299932052882
154,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.138842582784747,0.73299932052882
155,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.138996107186125,0.73299932052882
156,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.139532888640881,0.73299932052882
157,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.141108889740943,0.73299932052882
158,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.141954437857821,0.73299932052882
159,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,0.143515194499849,0.73299932052882
160,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.144974937898958,0.73299932052882
161,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.145775028699194,0.73299932052882
162,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.147834696990075,0.73299932052882
163,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.148546838560287,0.73299932052882
164,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.148992024871836,0.73299932052882
165,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.150562726825401,0.73299932052882
166,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.15205851919312,0.73299932052882
167,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.152988674686207,0.73299932052882
168,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.153248117757339,0.73299932052882
169,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.154405157491543,0.73299932052882
170,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.15513562868728,0.73299932052882
171,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.15617852159237,0.73299932052882
172,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.157140168372731,0.73299932052882
173,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.157141021393367,0.73299932052882
174,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.157686638938643,0.73299932052882
175,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,163,Down,0.159296703328014,0.73299932052882
176,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.160012746665962,0.73299932052882
177,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.161471208977431,0.73299932052882
178,WP_NAD_METABOLISM,11,Down,0.163263684104008,0.73299932052882
179,WP_PURINERGIC_SIGNALING,16,Down,0.163451129121419,0.73299932052882
180,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.163525893182018,0.73299932052882
181,WP_VALPROIC_ACID_PATHWAY,8,Up,0.163701984706003,0.73299932052882
182,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.163973870108128,0.73299932052882
183,WP_BDNFTRKB_SIGNALING,26,Down,0.165727704888305,0.73299932052882
184,WP_ENDOTHELIN_PATHWAYS,12,Up,0.166080850402431,0.73299932052882
185,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.16660529563957,0.73299932052882
186,WP_INSULIN_SIGNALING,126,Down,0.167536950911803,0.73299932052882
187,WP_TRYPTOPHAN_METABOLISM,17,Up,0.168819385384199,0.73299932052882
188,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.169303167163047,0.73299932052882
189,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,95,Down,0.172509946140863,0.73299932052882
190,WP_FRAGILE_X_SYNDROME,83,Down,0.1736495327002,0.73299932052882
191,WP_HEART_DEVELOPMENT,15,Down,0.173960122472771,0.73299932052882
192,WP_IL18_SIGNALING,190,Down,0.173996097289408,0.73299932052882
193,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Up,0.175772708215788,0.73299932052882
194,WP_PREIMPLANTATION_EMBRYO,20,Down,0.17582637555355,0.73299932052882
195,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.176281517658173,0.73299932052882
196,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.17748177466498,0.73299932052882
197,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.177513609460474,0.73299932052882
198,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.177618775099941,0.73299932052882
199,WP_DNA_REPLICATION,34,Up,0.178071306642715,0.73299932052882
200,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.178506211568831,0.73299932052882
201,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.178585289001567,0.73299932052882
202,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.180339363396686,0.733717643428332
203,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.181251492002581,0.733717643428332
204,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.181428362738642,0.733717643428332
205,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.18362499421149,0.738978635241362
206,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.18510604302974,0.741322745143378
207,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.187923318500407,0.74781339891544
208,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Down,0.188539620575044,0.74781339891544
209,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.191007845536666,0.748977980552393
210,WP_AXON_GUIDANCE,33,Down,0.193721272927355,0.748977980552393
211,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,74,Down,0.193871332930659,0.748977980552393
212,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.194991351425391,0.748977980552393
213,WP_MEASLES_VIRUS_INFECTION,99,Up,0.195914421682695,0.748977980552393
214,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.196537779255182,0.748977980552393
215,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.197018932561627,0.748977980552393
216,WP_STEROID_BIOSYNTHESIS,2,Down,0.197582288629756,0.748977980552393
217,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.197656400119511,0.748977980552393
218,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.19791175728536,0.748977980552393
219,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.199627555718783,0.749166476067848
220,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.201053411531914,0.749166476067848
221,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.201512867932403,0.749166476067848
222,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.201891241956846,0.749166476067848
223,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.202501968682582,0.749166476067848
224,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.206663016044103,0.759836672228237
225,WP_GLUTATHIONE_METABOLISM,10,Up,0.207228183334974,0.759836672228237
226,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Down,0.210078132822946,0.766004461717404
227,WP_AGERAGE_PATHWAY,55,Down,0.211978179430221,0.766004461717404
228,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.213486762249664,0.766004461717404
229,WP_CHEMOKINE_SIGNALING,114,Down,0.213860848020285,0.766004461717404
230,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.214857055935416,0.766004461717404
231,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.215301438772571,0.766004461717404
232,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.215880930747641,0.766004461717404
233,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.217354980538658,0.766004461717404
234,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,49,Down,0.219191196390016,0.766004461717404
235,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.22024948793957,0.766004461717404
236,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.220285151516114,0.766004461717404
237,WP_METHYLATION_PATHWAYS,5,Up,0.220726943990297,0.766004461717404
238,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.221826544581007,0.766004461717404
239,WP_MATRIX_METALLOPROTEINASES,10,Up,0.221915864281868,0.766004461717404
240,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.222837661590518,0.766004461717404
241,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.225571534056558,0.772184712019339
242,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Down,0.227813653755694,0.776637455985321
243,WP_RETINOL_METABOLISM,5,Down,0.229640415013143,0.779643384303881
244,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.234752660300211,0.793733380113418
245,WP_ZINC_HOMEOSTASIS,20,Up,0.236449400090555,0.794608695037328
246,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.236937865429312,0.794608695037328
247,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.238490308252365,0.794766356911046
248,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.23891158365326,0.794766356911046
249,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.242505244305546,0.802723324468248
250,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.243249492263105,0.802723324468248
251,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.248919519888781,0.814178497912709
252,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.249357640337231,0.814178497912709
253,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.249681406026564,0.814178497912709
254,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.25555915669197,0.820844380793929
255,WP_SPINA_BIFIDA,10,Down,0.255596508549561,0.820844380793929
256,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.257398075023607,0.820844380793929
257,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.258837487618296,0.820844380793929
258,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.259314367222023,0.820844380793929
259,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.260135807640156,0.820844380793929
260,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.260150161741111,0.820844380793929
261,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.261533496309473,0.820844380793929
262,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.263817231370438,0.820844380793929
263,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.263867764471035,0.820844380793929
264,WP_RETT_SYNDROME,30,Down,0.26633925538771,0.820844380793929
265,WP_ATM_SIGNALING,32,Down,0.266500143618581,0.820844380793929
266,WP_RAS_SIGNALING,113,Down,0.266610267759369,0.820844380793929
267,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.266805260628284,0.820844380793929
268,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.267823476933023,0.820844380793929
269,WP_DOPAMINE_METABOLISM,7,Down,0.267934174097443,0.820844380793929
270,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.268890964267353,0.820844380793929
271,WP_APOPTOSIS,69,Up,0.269634942054733,0.820844380793929
272,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.271037382568494,0.82208029639341
273,WP_LEPTIN_SIGNALING,70,Down,0.273160097442347,0.822984517149382
274,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.27450430833807,0.822984517149382
275,WP_EICOSANOID_SYNTHESIS,13,Down,0.27476244313524,0.822984517149382
276,WP_COPPER_HOMEOSTASIS,39,Up,0.275325729373611,0.822984517149382
277,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.277434404070337,0.826282952408201
278,WP_G_PROTEIN_SIGNALING,60,Down,0.27892877762225,0.826282952408201
279,WP_BREAST_CANCER_PATHWAY,82,Down,0.279611168086521,0.826282952408201
280,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Up,0.281097835652164,0.826282952408201
281,WP_MTHFR_DEFICIENCY,18,Down,0.281436981365702,0.826282952408201
282,WP_SLEEP_REGULATION,10,Down,0.283882077314915,0.826540144766425
283,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.284712375255951,0.826540144766425
284,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.285489311372406,0.826540144766425
285,WP_ARYLAMINE_METABOLISM,1,Up,0.28553205001022,0.826540144766425
286,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.286668640385436,0.826928770342604
287,WP_FOLATE_METABOLISM,36,Down,0.29074750741388,0.831761342999892
288,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.291768380956786,0.831761342999892
289,WP_FERROPTOSIS,48,Up,0.2926220780816,0.831761342999892
290,WP_MONOAMINE_GPCRS,4,Down,0.29314768153688,0.831761342999892
291,WP_NPHP1_DELETION_SYNDROME,10,Down,0.293384910076326,0.831761342999892
292,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.297439473351047,0.832098313726518
293,WP_HEME_BIOSYNTHESIS,8,Up,0.297439473351047,0.832098313726518
294,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.29858580955147,0.832098313726518
295,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.299475394260862,0.832098313726518
296,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.300504641796262,0.832098313726518
297,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.301383824431698,0.832098313726518
298,WP_IL11_SIGNALING,39,Down,0.301725466409349,0.832098313726518
299,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.305110393243961,0.832098313726518
300,WP_PDGFRBETA_PATHWAY,27,Up,0.305898764411038,0.832098313726518
301,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.306473793695354,0.832098313726518
302,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.306832289773706,0.832098313726518
303,WP_THERMOGENESIS,75,Down,0.306856082301296,0.832098313726518
304,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.307037865201113,0.832098313726518
305,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.308937382821674,0.832098313726518
306,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.30994104135933,0.832098313726518
307,WP_ALSTROM_SYNDROME,26,Down,0.310576771315504,0.832098313726518
308,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.310650037124567,0.832098313726518
309,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.313916832373313,0.834391427655925
310,WP_BENZOAPYRENE_METABOLISM,4,Down,0.313940536232949,0.834391427655925
311,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.314540283637567,0.834391427655925
312,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.316797844243293,0.837686607374091
313,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.320560174825144,0.83979676051509
314,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.322572172182064,0.83979676051509
315,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.323299098259052,0.83979676051509
316,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.325032196259075,0.83979676051509
317,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.325471104836294,0.83979676051509
318,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.326084079918206,0.83979676051509
319,WP_BENZENE_METABOLISM,3,Down,0.326621775516152,0.83979676051509
320,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.326817702059977,0.83979676051509
321,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.327161188363421,0.83979676051509
322,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Up,0.331250524020206,0.83979676051509
323,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Down,0.332008457447598,0.83979676051509
324,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.334320906719383,0.83979676051509
325,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.334697193426138,0.83979676051509
326,WP_NUCLEAR_RECEPTORS,21,Down,0.335386622855016,0.83979676051509
327,WP_PROSTAGLANDIN_SIGNALING,24,Down,0.335398348808271,0.83979676051509
328,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.335760759450746,0.83979676051509
329,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.336527551941943,0.83979676051509
330,WP_HISTONE_MODIFICATIONS,35,Up,0.336856100418555,0.83979676051509
331,WP_15Q11Q13_COPY_NUMBER_VARIATION,28,Up,0.336942167699096,0.83979676051509
332,WP_IL5_SIGNALING,37,Down,0.337954575140618,0.83979676051509
333,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.340758360606354,0.843342661467382
334,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.345718997165649,0.843342661467382
335,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.347634809534966,0.843342661467382
336,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.348892510053371,0.843342661467382
337,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.350230739711321,0.843342661467382
338,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.351314504090436,0.843342661467382
339,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.3526620512217,0.843342661467382
340,WP_DNA_MISMATCH_REPAIR,21,Up,0.352665435519547,0.843342661467382
341,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.352696223594799,0.843342661467382
342,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.354373383535416,0.843342661467382
343,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.354477265015115,0.843342661467382
344,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.354510913462743,0.843342661467382
345,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.354643499911398,0.843342661467382
346,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.355386321772819,0.843342661467382
347,WP_OSTEOCLAST_SIGNALING,9,Up,0.355391856887986,0.843342661467382
348,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.355737268109877,0.843342661467382
349,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.361517654447224,0.851994545971704
350,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.361783145271528,0.851994545971704
351,WP_SPHINGOLIPID_PATHWAY,21,Up,0.362484952286143,0.851994545971704
352,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.367233717667306,0.855408879328313
353,WP_AMINO_ACID_METABOLISM,57,Down,0.367757179336962,0.855408879328313
354,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.368696239989946,0.855408879328313
355,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.370783250720576,0.855408879328313
356,WP_IL26_SIGNALING,33,Down,0.371529766104422,0.855408879328313
357,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Down,0.373253819172912,0.855408879328313
358,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.373410458339489,0.855408879328313
359,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.374160821915737,0.855408879328313
360,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Down,0.374904400674564,0.855408879328313
361,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.378577180151134,0.855408879328313
362,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.37893357152377,0.855408879328313
363,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.379547448431498,0.855408879328313
364,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.379856700372564,0.855408879328313
365,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.380409402171139,0.855408879328313
366,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.380658979701426,0.855408879328313
367,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.380998511810503,0.855408879328313
368,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Down,0.381564203142811,0.855408879328313
369,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.384036450235122,0.858618079793973
370,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.386208019892108,0.861139503813485
371,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.388519052039782,0.863957460735363
372,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.390905301572712,0.866927080100772
373,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.392463070790385,0.867931985766872
374,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.393462500214315,0.867931985766872
375,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.396819604391211,0.871775373582076
376,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.399779826687876,0.871775373582076
377,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.402551395304752,0.871775373582076
378,WP_GLUCURONIDATION,7,Up,0.40316538223033,0.871775373582076
379,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.403365712827675,0.871775373582076
380,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.403365712827675,0.871775373582076
381,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.405034325683821,0.871775373582076
382,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.405182833499711,0.871775373582076
383,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.406065797957756,0.871775373582076
384,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.406235327891636,0.871775373582076
385,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.407309689805007,0.871775373582076
386,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.407885205094159,0.871775373582076
387,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.412273200300234,0.874530435907274
388,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.41606131917601,0.874530435907274
389,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.417917044949146,0.874530435907274
390,WP_CYTOSINE_METHYLATION,7,Down,0.418648609235323,0.874530435907274
391,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.419372254322422,0.874530435907274
392,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.419824767326444,0.874530435907274
393,WP_OVARIAN_INFERTILITY,21,Down,0.421060308571511,0.874530435907274
394,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.422031474403934,0.874530435907274
395,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.42322800564175,0.874530435907274
396,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.423714221700081,0.874530435907274
397,WP_VITAMIN_B12_METABOLISM,24,Down,0.423994738924622,0.874530435907274
398,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,81,Down,0.424272984337393,0.874530435907274
399,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.424927537692159,0.874530435907274
400,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.425196591357805,0.874530435907274
401,WP_ESTROGEN_SIGNALING,21,Down,0.425695644690399,0.874530435907274
402,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Down,0.426134830587545,0.874530435907274
403,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.428952747882521,0.874752403089328
404,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.429045656177197,0.874752403089328
405,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.429423906971125,0.874752403089328
406,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.431296706678894,0.875545172619623
407,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.432469961546374,0.875545172619623
408,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.43299688536825,0.875545172619623
409,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.435011233868377,0.876367056991253
410,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.435527870747168,0.876367056991253
411,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.439662811361681,0.882534840324541
412,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.441430241097269,0.883931914818561
413,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.443929727367754,0.886784564354472
414,WP_NOTCH_SIGNALING_WP268,33,Down,0.446497069347095,0.88835874703967
415,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.447903085811734,0.88835874703967
416,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.448346610057372,0.88835874703967
417,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.450223098974787,0.88835874703967
418,WP_ECTODERM_DIFFERENTIATION,72,Up,0.451334609726264,0.88835874703967
419,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.453408740290524,0.88835874703967
420,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.455267589496168,0.88835874703967
421,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.457799288065259,0.88835874703967
422,WP_PYRIMIDINE_METABOLISM,71,Up,0.458258002614552,0.88835874703967
423,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.45896083890168,0.88835874703967
424,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.459279156264588,0.88835874703967
425,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Down,0.459318850759527,0.88835874703967
426,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.461533407196834,0.88835874703967
427,WP_CILIARY_LANDSCAPE,180,Down,0.462588960327741,0.88835874703967
428,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.463695290105328,0.88835874703967
429,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.463970735057479,0.88835874703967
430,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.464815332731069,0.88835874703967
431,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.465959004021415,0.88835874703967
432,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.466403842422652,0.88835874703967
433,WP_CHOLESTEROL_METABOLISM,49,Down,0.467096297064652,0.88835874703967
434,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.467755799785737,0.88835874703967
435,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.468934950716981,0.88835874703967
436,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.46948413782945,0.88835874703967
437,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.470947036940386,0.889087655551072
438,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.474079499292841,0.892957960996789
439,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.476190979017057,0.894115634485292
440,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.476861671725489,0.894115634485292
441,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Down,0.478229821273844,0.894647624832021
442,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.483578713055844,0.895200723649207
443,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.486353540884207,0.895200723649207
444,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.4878158416881,0.895200723649207
445,WP_IL2_SIGNALING,37,Down,0.488612545396033,0.895200723649207
446,WP_TGFB_SMAD_SIGNALING,6,Up,0.493514251027863,0.895200723649207
447,WP_AEROBIC_GLYCOLYSIS,9,Down,0.496265612610311,0.895200723649207
448,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.496265612610311,0.895200723649207
449,WP_CAMKK2_PATHWAY,29,Down,0.497166699981919,0.895200723649207
450,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.498154469231905,0.895200723649207
451,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.498962918874824,0.895200723649207
452,WP_TAR_SYNDROME,44,Down,0.499903170938669,0.895200723649207
453,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.500487318134138,0.895200723649207
454,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.501155265137238,0.895200723649207
455,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.504929225322051,0.895200723649207
456,WP_KININKALLIKREIN_PATHWAY,2,Down,0.505537558175287,0.895200723649207
457,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.506484039234117,0.895200723649207
458,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.507479757734881,0.895200723649207
459,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.508964957430208,0.895200723649207
460,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.509218416106927,0.895200723649207
461,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.510066769197291,0.895200723649207
462,WP_MACROPHAGE_MARKERS,8,Down,0.511310232684886,0.895200723649207
463,WP_FOXP3_IN_COVID19,9,Down,0.511358814928417,0.895200723649207
464,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.511935600178223,0.895200723649207
465,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.51230926041404,0.895200723649207
466,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.512568021330972,0.895200723649207
467,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.512680144987358,0.895200723649207
468,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.513404833373351,0.895200723649207
469,WP_SERINE_METABOLISM,7,Up,0.513831161549962,0.895200723649207
470,WP_BLADDER_CANCER,30,Down,0.514614850843698,0.895200723649207
471,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.514712675698478,0.895200723649207
472,WP_SMALL_CELL_LUNG_CANCER,64,Down,0.515032048109895,0.895200723649207
473,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Down,0.51605785634158,0.895200723649207
474,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.517870643131196,0.895200723649207
475,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.517870643131196,0.895200723649207
476,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Up,0.518037924916197,0.895200723649207
477,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.519382783788644,0.895200723649207
478,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.51991946153295,0.895200723649207
479,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.520456564179212,0.895200723649207
480,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.520844057395902,0.895200723649207
481,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.521982362727848,0.895291994283731
482,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.524575429168448,0.897096523021873
483,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.525209237114624,0.897096523021873
484,WP_ENDOMETRIAL_CANCER,48,Down,0.528078493771729,0.900133796201811
485,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.532514868004429,0.905824260007534
486,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.537689786613555,0.911926726081006
487,WP_PRION_DISEASE_PATHWAY,29,Down,0.538313109819939,0.911926726081006
488,WP_HIPPOYAP_SIGNALING,15,Down,0.540733600924579,0.913603060960118
489,WP_SEROTONIN_AND_ANXIETY,6,Down,0.541517475276853,0.913603060960118
490,WP_IL7_SIGNALING,24,Down,0.543130556016708,0.913603060960118
491,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.543732245977476,0.913603060960118
492,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.545114282134315,0.913959793441895
493,WP_IDO_METABOLIC_PATHWAY,6,Up,0.546160215959823,0.913959793441895
494,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.547941050206762,0.915083737693479
495,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Up,0.551550372856692,0.91566711240337
496,WP_ADIPOGENESIS,80,Up,0.554275662124693,0.91566711240337
497,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.554372273426881,0.91566711240337
498,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.55539688339478,0.91566711240337
499,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Down,0.559981941247491,0.91566711240337
500,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.560854491480177,0.91566711240337
501,WP_WNT_SIGNALING_WP363,40,Down,0.562587780205452,0.91566711240337
502,WP_MRNA_PROCESSING,124,Down,0.562743171758969,0.91566711240337
503,WP_WNT_SIGNALING_WP428,58,Down,0.564576106717885,0.91566711240337
504,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.564660888164113,0.91566711240337
505,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.565136500944009,0.91566711240337
506,WP_HUNGER_AND_SATIETY,2,Up,0.567364908428576,0.91566711240337
507,WP_OSTEOPONTIN_SIGNALING,12,Down,0.567365847973151,0.91566711240337
508,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.567873829339908,0.91566711240337
509,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.56874434187691,0.91566711240337
510,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.569710573262817,0.91566711240337
511,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.570095830165782,0.91566711240337
512,WP_FOXA2_PATHWAY,9,Down,0.570322266732044,0.91566711240337
513,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.573220208208209,0.91566711240337
514,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.573739699507715,0.91566711240337
515,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.574105234294931,0.91566711240337
516,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.575008215889558,0.91566711240337
517,WP_PPARALPHA_PATHWAY,15,Up,0.577309396223024,0.91566711240337
518,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.577508137975557,0.91566711240337
519,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Down,0.577756892507177,0.91566711240337
520,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.580500336829911,0.91566711240337
521,WP_VITAMIN_D_METABOLISM,6,Down,0.581233409347357,0.91566711240337
522,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.582354597264517,0.91566711240337
523,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.582733361188652,0.91566711240337
524,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.583249139764058,0.91566711240337
525,WP_NEPHROTIC_SYNDROME,26,Up,0.583293094004556,0.91566711240337
526,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.584605308385362,0.91566711240337
527,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.584917052407971,0.91566711240337
528,WP_PPAR_SIGNALING,37,Down,0.586778291649062,0.915993926792901
529,WP_SMALL_LIGAND_GPCRS,7,Down,0.587406395184331,0.915993926792901
530,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.588456704485137,0.915993926792901
531,WP_LUNG_FIBROSIS,35,Down,0.589726048922106,0.916241036460899
532,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.592615744796614,0.917105748284553
533,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.59303308748458,0.917105748284553
534,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.594029309020552,0.917105748284553
535,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.59578981215986,0.917105748284553
536,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.595840825552146,0.917105748284553
537,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.597836062707941,0.918463224830635
538,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.608692143220554,0.930240875178379
539,WP_DRAVET_SYNDROME,12,Down,0.609914123534892,0.930240875178379
540,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.611139849729913,0.930240875178379
541,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Up,0.611668014949625,0.930240875178379
542,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.614399082911317,0.930240875178379
543,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.614399082911317,0.930240875178379
544,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Up,0.61507719370521,0.930240875178379
545,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.616648279777657,0.930240875178379
546,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.616984138392126,0.930240875178379
547,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.617191383888641,0.930240875178379
548,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Down,0.619572301287614,0.930240875178379
549,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.619981333625286,0.930240875178379
550,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.620160583452252,0.930240875178379
551,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.623147707234751,0.931764266275959
552,WP_IL19_SIGNALING,20,Down,0.623970459698163,0.931764266275959
553,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.624564411212855,0.931764266275959
554,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.625888425698958,0.931808136446747
555,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.627232613489833,0.931808136446747
556,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.629925568955115,0.931808136446747
557,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.629980342850002,0.931808136446747
558,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.630241139560345,0.931808136446747
559,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.634715256036831,0.932115977966931
560,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.635867744972236,0.932115977966931
561,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.637276480943621,0.932115977966931
562,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.638258689248784,0.932115977966931
563,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.640648111770282,0.932115977966931
564,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.64231992352081,0.932115977966931
565,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.642586565764972,0.932115977966931
566,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.642919721468123,0.932115977966931
567,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.643287569451744,0.932115977966931
568,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Down,0.643711429402016,0.932115977966931
569,WP_ENERGY_METABOLISM,41,Up,0.644738239760763,0.932115977966931
570,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Down,0.644830865002676,0.932115977966931
571,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.645137240508021,0.932115977966931
572,WP_NOTCH_SIGNALING_WP61,48,Up,0.646576237493735,0.932561881000579
573,WP_15Q25_COPY_NUMBER_VARIATION,26,Down,0.650310524024595,0.935080763329108
574,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.651813431807605,0.935080763329108
575,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,6,Up,0.652115524691977,0.935080763329108
576,WP_MALE_INFERTILITY,71,Down,0.652856387487959,0.935080763329108
577,WP_NEUROINFLAMMATION,10,Down,0.657404433910358,0.938466359798442
578,WP_TNFALPHA_SIGNALING,81,Down,0.659679689245152,0.938466359798442
579,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.660394863912272,0.938466359798442
580,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,80,Down,0.6606923990469,0.938466359798442
581,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.661116121087144,0.938466359798442
582,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.662045359275991,0.938466359798442
583,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.66456556173378,0.938772279240116
584,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.666323840679009,0.938772279240116
585,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.667485636723411,0.938772279240116
586,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.668738498847762,0.938772279240116
587,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.670331735331395,0.938772279240116
588,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.674807915872469,0.938772279240116
589,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.677456711724154,0.938772279240116
590,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.678151701603704,0.938772279240116
591,WP_CANCER_PATHWAYS,292,Down,0.678825212063064,0.938772279240116
592,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.679283543789595,0.938772279240116
593,WP_MELANOMA,53,Down,0.679338420939163,0.938772279240116
594,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Up,0.680239066997508,0.938772279240116
595,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.681040860508118,0.938772279240116
596,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.682048203907687,0.938772279240116
597,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.683208633895129,0.938772279240116
598,WP_GLYOXYLATE_METABOLISM,5,Up,0.684465112042919,0.938772279240116
599,WP_BARDETBIEDL_SYNDROME,61,Up,0.68882235478393,0.938772279240116
600,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.689026308015693,0.938772279240116
601,WP_IL9_SIGNALING,15,Down,0.690245483423297,0.938772279240116
602,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.690407418098196,0.938772279240116
603,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.691477122548752,0.938772279240116
604,WP_IL4_SIGNALING,50,Down,0.691788478895118,0.938772279240116
605,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Up,0.692020049535236,0.938772279240116
606,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.694723037982971,0.938772279240116
607,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.695815944904611,0.938772279240116
608,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.697663439731838,0.938772279240116
609,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.697767296488178,0.938772279240116
610,WP_NUCLEAR_RECEPTORS_METAPATHWAY,174,Down,0.698016669259686,0.938772279240116
611,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.698415732621894,0.938772279240116
612,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.698577070487838,0.938772279240116
613,WP_NUCLEOTIDE_GPCRS,7,Down,0.700955249557755,0.938772279240116
614,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.701012210164411,0.938772279240116
615,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.701766465311378,0.938772279240116
616,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Up,0.701906054399798,0.938772279240116
617,WP_MEVALONATE_PATHWAY,7,Down,0.702651940703957,0.938772279240116
618,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.705386515158932,0.938772279240116
619,WP_KREBS_CYCLE_DISORDERS,11,Down,0.705449418163256,0.938772279240116
620,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.707009465036626,0.938772279240116
621,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.708944983416535,0.938772279240116
622,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.709178268787068,0.938772279240116
623,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.70953969534803,0.938772279240116
624,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.710053214843433,0.938772279240116
625,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.71312753960546,0.939605901035722
626,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.715015500105423,0.939605901035722
627,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.716643732094171,0.939605901035722
628,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.716998835351088,0.939605901035722
629,WP_NRF2_PATHWAY,69,Up,0.717018631009845,0.939605901035722
630,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.720370797052295,0.939605901035722
631,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,4,Down,0.720388279980677,0.939605901035722
632,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.721834139845873,0.939605901035722
633,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.722013481775042,0.939605901035722
634,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.722072898492907,0.939605901035722
635,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.727607705004675,0.942744033892174
636,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.728211466186778,0.942744033892174
637,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.728485897138078,0.942744033892174
638,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.730090097040754,0.942744033892174
639,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.730198106251029,0.942744033892174
640,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Down,0.736802602780936,0.94701283480199
641,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.737303868760402,0.94701283480199
642,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.737679012728475,0.94701283480199
643,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.740131133438527,0.94701283480199
644,WP_CELLULAR_PROTEOSTASIS,6,Down,0.743761905883942,0.94701283480199
645,WP_10Q22Q23_COPY_NUMBER_VARIATION,26,Up,0.745865750086852,0.94701283480199
646,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,27,Down,0.748739890936382,0.94701283480199
647,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Up,0.749256905420112,0.94701283480199
648,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.750876290184839,0.94701283480199
649,WP_NEPHROGENESIS,3,Down,0.750920492717296,0.94701283480199
650,WP_KALLMANN_SYNDROME,11,Up,0.751601089381733,0.94701283480199
651,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.751697129977002,0.94701283480199
652,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.75435066102942,0.94701283480199
653,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.754381189044599,0.94701283480199
654,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.755171432534382,0.94701283480199
655,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.755222794173199,0.94701283480199
656,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.755239793237425,0.94701283480199
657,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.755887790504332,0.94701283480199
658,WP_G13_SIGNALING,30,Down,0.756312935199192,0.94701283480199
659,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.7621802666863,0.94701283480199
660,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.762619935559219,0.94701283480199
661,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.762702259189281,0.94701283480199
662,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Down,0.766148626499282,0.94701283480199
663,WP_BASE_EXCISION_REPAIR,29,Up,0.766459108010127,0.94701283480199
664,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,61,Down,0.767133590957772,0.94701283480199
665,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.767150872320077,0.94701283480199
666,WP_ANGIOGENESIS,14,Down,0.769383228272833,0.94701283480199
667,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.770333255355182,0.94701283480199
668,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.773347026668305,0.94701283480199
669,WP_PHOSPHOINOSITIDES_METABOLISM,37,Up,0.774258893390753,0.94701283480199
670,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.775617861555362,0.94701283480199
671,WP_COMPLEMENT_SYSTEM,52,Down,0.77657069196668,0.94701283480199
672,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.776818756030154,0.94701283480199
673,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.777577616120094,0.94701283480199
674,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.778447591283574,0.94701283480199
675,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Up,0.779757323616044,0.94701283480199
676,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.780278742345335,0.94701283480199
677,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.782852204580398,0.94701283480199
678,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Up,0.783796905048876,0.94701283480199
679,WP_TYPE_II_DIABETES_MELLITUS,12,Down,0.784337179541482,0.94701283480199
680,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.785226547479318,0.94701283480199
681,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.789488069679823,0.94701283480199
682,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.789529488215705,0.94701283480199
683,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.790419779341233,0.94701283480199
684,WP_ALZHEIMERS_DISEASE,183,Down,0.794036213140542,0.94701283480199
685,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.794036213140542,0.94701283480199
686,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.795564987919883,0.94701283480199
687,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.796103232809075,0.94701283480199
688,WP_IL3_SIGNALING,45,Down,0.797241378689414,0.94701283480199
689,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.797271369863601,0.94701283480199
690,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.800571688233184,0.94701283480199
691,WP_TAMOXIFEN_METABOLISM,3,Down,0.800644779384961,0.94701283480199
692,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.800763480215391,0.94701283480199
693,WP_ONECARBON_METABOLISM,22,Down,0.801680473635717,0.94701283480199
694,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.802020417833316,0.94701283480199
695,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.802876372132249,0.94701283480199
696,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.802935629208601,0.94701283480199
697,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.803304803890777,0.94701283480199
698,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.80426437454698,0.94701283480199
699,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.805109718326398,0.94701283480199
700,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.805329680071315,0.94701283480199
701,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.806107670645516,0.94701283480199
702,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.807250056117673,0.94701283480199
703,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.807386416032122,0.94701283480199
704,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.809199461708746,0.94701283480199
705,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.809265513376246,0.94701283480199
706,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.813634314465845,0.950776642258247
707,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Down,0.817567609201952,0.950868150371976
708,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Down,0.817567609201952,0.950868150371976
709,WP_GASTRIC_CANCER_NETWORK_2,25,Down,0.817641407747792,0.950868150371976
710,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.818322893047397,0.950868150371976
711,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Up,0.822254139737366,0.953800985023685
712,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.825213057706316,0.953800985023685
713,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.826508936403152,0.953800985023685
714,WP_OSTEOBLAST_SIGNALING,2,Down,0.826517656333502,0.953800985023685
715,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.827769644971691,0.953800985023685
716,WP_AUTOPHAGY,27,Down,0.828700228609348,0.953800985023685
717,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.830085433992719,0.953800985023685
718,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.831667165073762,0.953800985023685
719,WP_SILDENAFIL_TREATMENT,11,Down,0.83195104676231,0.953800985023685
720,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.833292029684631,0.953800985023685
721,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.833564254790396,0.953800985023685
722,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.83861704396568,0.956422284166311
723,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.839369634614169,0.956422284166311
724,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,13,Down,0.839802383419482,0.956422284166311
725,WP_PI3KAKT_SIGNALING,174,Down,0.84049231032797,0.956422284166311
726,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.84306861101663,0.958032512518898
727,WP_CELL_CYCLE,87,Down,0.845277524830478,0.958524802027781
728,WP_SULINDAC_METABOLIC_PATHWAY,3,Down,0.846248383923636,0.958524802027781
729,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.847472027589582,0.958524802027781
730,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Down,0.848149218763976,0.958524802027781
731,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.850506143383687,0.959561134485887
732,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.851953219739164,0.959561134485887
733,WP_PTF1A_RELATED_REGULATORY_PATHWAY,4,Down,0.852555529185643,0.959561134485887
734,WP_INTEGRATED_CANCER_PATHWAY,37,Down,0.854786184163597,0.960761038058538
735,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.856510076474249,0.961388861348647
736,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.860851731869227,0.963491762122704
737,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.861171828538744,0.963491762122704
738,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.861905249424725,0.963491762122704
739,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.864293014650537,0.963491762122704
740,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.865156138885946,0.963491762122704
741,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.866409636681264,0.963491762122704
742,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.866558651509147,0.963491762122704
743,WP_FOCAL_ADHESION,117,Up,0.869476653835191,0.965435046317676
744,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Up,0.871293329646577,0.966151877632293
745,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.874804361854892,0.968743085275552
746,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.876176395556672,0.968961831547258
747,WP_CILIOPATHIES,114,Up,0.877891600843436,0.969558996915441
748,WP_CHOLESTASIS,9,Up,0.881763667026099,0.971244923830901
749,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,20,Up,0.886272867099494,0.971244923830901
750,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.887817686195803,0.971244923830901
751,WP_IRON_METABOLISM_DISORDERS,12,Down,0.889444694927924,0.971244923830901
752,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.890695382999737,0.971244923830901
753,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.891430557205767,0.971244923830901
754,WP_MIRNA_BIOGENESIS,6,Up,0.891859720753637,0.971244923830901
755,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.892682665179273,0.971244923830901
756,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.892858280660411,0.971244923830901
757,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,120,Down,0.892864082075133,0.971244923830901
758,WP_TRANSSULFURATION_PATHWAY,8,Down,0.894076014106036,0.971244923830901
759,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.89469950382364,0.971244923830901
760,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.896382630176618,0.971244923830901
761,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Up,0.896516473158672,0.971244923830901
762,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.89707712964745,0.971244923830901
763,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.900233304776584,0.971878325427019
764,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.901326555939262,0.971878325427019
765,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.901390782472741,0.971878325427019
766,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.902374299729814,0.971878325427019
767,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.904175481766046,0.972548595119932
768,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.90638275843817,0.973653353791002
769,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.909666338843023,0.975909921385558
770,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.911799752544167,0.976928306297322
771,WP_PANCREATIC_CANCER_SUBTYPES,4,Down,0.91397387173195,0.977987605938857
772,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,54,Down,0.917654730648904,0.9794161655438
773,WP_ID_SIGNALING,11,Down,0.917683267836796,0.9794161655438
774,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.920199082191718,0.980121928793944
775,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.92072059977613,0.980121928793944
776,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.922156908065702,0.980385888085314
777,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Up,0.926235899100288,0.982770652848516
778,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.928678996636004,0.982770652848516
779,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.92932053607718,0.982770652848516
780,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.93033129856155,0.982770652848516
781,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.930356218029929,0.982770652848516
782,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.933484713249995,0.984493089712691
783,WP_PEPTIDE_GPCRS,14,Down,0.934759437206508,0.984493089712691
784,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.935566766466363,0.984493089712691
785,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Down,0.936866762237924,0.984605195982532
786,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.941365319959516,0.985730648428626
787,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Down,0.94150006749758,0.985730648428626
788,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.942167063667106,0.985730648428626
789,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Up,0.943472718014732,0.985730648428626
790,WP_IL17_SIGNALING,24,Up,0.943911772434684,0.985730648428626
791,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.945484126302715,0.986124404803716
792,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.947875197373655,0.986512635910943
793,WP_DNA_DAMAGE_RESPONSE,56,Down,0.948247903366519,0.986512635910943
794,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.950629963266413,0.987513198337009
795,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.952687264898898,0.987513198337009
796,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,69,Down,0.952800613183344,0.987513198337009
797,WP_PROTEASOME_DEGRADATION,57,Up,0.954989114873765,0.987970579923236
798,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.955659890629798,0.987970579923236
799,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.956834537404444,0.987970579923236
800,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.959736573662191,0.989728341589135
801,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.964536341999856,0.991113105926477
802,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.964549985517945,0.991113105926477
803,WP_CORI_CYCLE,11,Down,0.965005780618396,0.991113105926477
804,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.96696455781476,0.991113105926477
805,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Up,0.967854582960153,0.991113105926477
806,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.970796624645755,0.991113105926477
807,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.971474007630548,0.991113105926477
808,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.972179357021208,0.991113105926477
809,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.972999366988083,0.991113105926477
810,WP_HEPATITIS_B_INFECTION,118,Down,0.973456093777474,0.991113105926477
811,WP_IL6_SIGNALING,39,Down,0.97429421685621,0.991113105926477
812,WP_P38_MAPK_SIGNALING,31,Down,0.979284664357092,0.994193045060197
813,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.980750173284793,0.994193045060197
814,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.981187537184685,0.994193045060197
815,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,2,Up,0.984252839219688,0.994193045060197
816,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.984252839219688,0.994193045060197
817,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,25,Down,0.986674411094988,0.994193045060197
818,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.987591278532785,0.994193045060197
819,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Up,0.98780261345453,0.994193045060197
820,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Down,0.988167632665893,0.994193045060197
821,WP_CCL18_SIGNALING,23,Up,0.991636848291685,0.996468209306504
822,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.994026879294932,0.997244139947305
823,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.99564130318715,0.997244139947305
824,WP_JOUBERT_SYNDROME,66,Up,0.996091287034726,0.997244139947305
825,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.997244139947305,0.997244139947305
